Liven Pharma Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 4, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	4,369	6,042	110	185	152	303
Market Cap Growth	-25.29%	5370.54%	-40.46%	21.91%	-49.80%	127.48%
Enterprise Value	4,218	6,080	349	423	387	535
Last Close Price	38.65	55.17	7.74	13.00	10.66	21.24
PE Ratio	-	-	2.65	-	-	-
PS Ratio	44.08	47.47	0.45	-	-	-
PB Ratio	5.28	9.53	0.15	-1.51	-1.38	-3.16
P/TBV Ratio	5.33	9.66	0.15	-	-	-
P/FCF Ratio	23.65	-	8.00	-	-	-
P/OCF Ratio	20.14	-	8.00	-	-	-
EV/Sales Ratio	42.56	47.77	1.42	-	-	-
EV/EBITDA Ratio	-	-	5.37	-	-	-
EV/EBIT Ratio	-	-	8.35	-	-	-
EV/FCF Ratio	22.83	-	25.26	-	-	-
Debt / Equity Ratio	0.03	0.06	0.21	-1.94	-2.13	-2.43
Debt / EBITDA Ratio	-	-	2.35	-	-	-
Debt / FCF Ratio	0.15	-	11.37	-	-	-
Net Debt / Equity Ratio	-0.18	0.04	0.18	-1.94	-2.13	-2.43
Net Debt / EBITDA Ratio	0.30	-0.06	2.03	-111.87	-79.65	-110.82
Net Debt / FCF Ratio	-0.82	-1.09	9.56	-104.83	-104.11	-34.31
Asset Turnover	0.10	0.14	0.46	-	-	-
Inventory Turnover	0.70	0.90	-	-	-	-
Quick Ratio	2.27	0.19	0.71	0	0	0
Current Ratio	3.79	1.64	1.48	0	0	0.00
Return on Equity (ROE)	-81.35%	-84.49%	13.31%	-	-	-
Return on Assets (ROA)	-33.95%	-35.12%	4.93%	-6.89%	-7.20%	-6.80%
Return on Capital Employed (ROCE)	-59.00%	-67.10%	5.60%	14.20%	19.10%	24.50%
Earnings Yield	-16.05%	-9.67%	37.80%	-6.65%	-9.39%	-4.83%
FCF Yield	4.23%	-0.41%	12.50%	-1.22%	-1.49%	-2.24%
Buyback Yield / Dilution	-172.01%	-174375.69%	99.67%	-	-	-